{"id":"https://openalex.org/W3175225331","doi":"https://doi.org/10.1136/annrheumdis-2021-220439","title":"Serum uric acid control for prevention of gout flare in patients with asymptomatic hyperuricaemia: a retrospective cohort study of health insurance claims and medical check-up data in Japan","display_name":"Serum uric acid control for prevention of gout flare in patients with asymptomatic hyperuricaemia: a retrospective cohort study of health insurance claims and medical check-up data in Japan","publication_year":2021,"publication_date":"2021-06-22","ids":{"openalex":"https://openalex.org/W3175225331","doi":"https://doi.org/10.1136/annrheumdis-2021-220439","mag":"3175225331","pmid":"https://pubmed.ncbi.nlm.nih.gov/34158371","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8522452"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2021-220439","doi":"https://doi.org/10.1136/annrheumdis-2021-220439","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2021-220439","pdf_url":"https://ard.bmj.com/content/annrheumdis/80/11/1483.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ard.bmj.com/content/annrheumdis/80/11/1483.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054338140","display_name":"Ruriko Koto","orcid":"https://orcid.org/0000-0001-9201-1273","observed_orcids":["https://orcid.org/0000-0001-9201-1273"]},"institutions":[{"id":"https://openalex.org/I4405268147","display_name":"Teijin Pharma Limited (Japan)","ror":"https://ror.org/001144c36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405268147"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Ruriko Koto","raw_affiliation_strings":["Medical Science Department, Teijin Pharma Limited, Chiyoda-ku, Tokyo, Japan r.koutou@teijin.co.jp","Medical Science Department, Teijin Pharma Limited, Chiyoda-ku, Tokyo 100-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Science Department, Teijin Pharma Limited, Chiyoda-ku, Tokyo, Japan r.koutou@teijin.co.jp","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]},{"raw_affiliation_string":"Medical Science Department, Teijin Pharma Limited, Chiyoda-ku, Tokyo 100-8585, Japan","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018149450","display_name":"Akihiro Nakajima","orcid":"https://orcid.org/0000-0003-4992-2586","observed_orcids":["https://orcid.org/0000-0003-4992-2586"]},"institutions":[{"id":"https://openalex.org/I4405268147","display_name":"Teijin Pharma Limited (Japan)","ror":"https://ror.org/001144c36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405268147"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akihiro Nakajima","raw_affiliation_strings":["Pharmaceutical Development Administration Department, Teijin Pharma Limited, Chiyoda-ku, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Development Administration Department, Teijin Pharma Limited, Chiyoda-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015614202","display_name":"Hideki Horiuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268147","display_name":"Teijin Pharma Limited (Japan)","ror":"https://ror.org/001144c36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405268147"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideki Horiuchi","raw_affiliation_strings":["Medical Science Department, Teijin Pharma Limited, Chiyoda-ku, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Science Department, Teijin Pharma Limited, Chiyoda-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063192431","display_name":"Hisashi Yamanaka","orcid":"https://orcid.org/0000-0001-8453-6731","observed_orcids":["https://orcid.org/0000-0001-8453-6731"]},"institutions":[{"id":"https://openalex.org/I4210136522","display_name":"Tokyo Women's Medical University","ror":"https://ror.org/03kjjhe36","country_code":"JP","type":"education","lineage":["https://openalex.org/I4210136522"]},{"id":"https://openalex.org/I4210162813","display_name":"Sanno Medical Center","ror":"https://ror.org/055mpn097","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210162813"]},{"id":"https://openalex.org/I79072001","display_name":"International University of Health and Welfare","ror":"https://ror.org/053d3tv41","country_code":"JP","type":"education","lineage":["https://openalex.org/I79072001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hisashi Yamanaka","raw_affiliation_strings":["Department of Rheumatology, International University of Health and Welfare, Chiba, Japan","Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan","Rheumatology, Sanno Medical Center, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, International University of Health and Welfare, Chiba, Japan","institution_ids":["https://openalex.org/I79072001"]},{"raw_affiliation_string":"Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan","institution_ids":["https://openalex.org/I4210136522"]},{"raw_affiliation_string":"Rheumatology, Sanno Medical Center, Tokyo, Japan","institution_ids":["https://openalex.org/I4210162813"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5054338140"],"corresponding_institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":{"value":4870,"currency":"USD","value_usd":4870},"fwci":4.6933,"has_fulltext":true,"cited_by_count":39,"citation_normalized_percentile":{"value":0.96271511,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"80","issue":"11","first_page":"1483","last_page":"1490"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serum-uric-acid","display_name":"serum uric acid","score":0.8259999752044678},{"id":"https://openalex.org/keywords/asymptomatic-hyperuricaemia","display_name":"asymptomatic hyperuricaemia","score":0.9599999785423279},{"id":"https://openalex.org/keywords/gout-flares","display_name":"gout flares","score":0.9110000133514404},{"id":"https://openalex.org/keywords/urate-lowering-therapy","display_name":"urate-lowering therapy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/serum-uric-acid-target","display_name":"serum uric acid target","score":0.621999979019165},{"id":"https://openalex.org/keywords/gout-prevention","display_name":"gout prevention","score":0.7549999952316284},{"id":"https://openalex.org/keywords/health-insurance-claims-data","display_name":"health insurance claims data","score":0.6940000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9442411065101624},{"id":"https://openalex.org/C2780402116","wikidata":"https://www.wikidata.org/wiki/Q133087","display_name":"Gout","level":2,"score":0.8854901790618896},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.7987847924232483},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6411364674568176},{"id":"https://openalex.org/C2779721657","wikidata":"https://www.wikidata.org/wiki/Q49970","display_name":"Hyperuricemia","level":3,"score":0.5860833525657654},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5290942192077637},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5092190504074097},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4921075701713562},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.43091288208961487},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4207390546798706},{"id":"https://openalex.org/C2780932893","wikidata":"https://www.wikidata.org/wiki/Q417296","display_name":"Febuxostat","level":4,"score":0.418178915977478},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.4013007581233978},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3229045271873474},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.07310757040977478},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067251","descriptor_name":"Symptom Flare Up","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006073","descriptor_name":"Gout","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006073","descriptor_name":"Gout","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006074","descriptor_name":"Gout Suppressants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014527","descriptor_name":"Uric Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D033461","descriptor_name":"Hyperuricemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D033461","descriptor_name":"Hyperuricemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058070","descriptor_name":"Asymptomatic Diseases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1136/annrheumdis-2021-220439","doi":"https://doi.org/10.1136/annrheumdis-2021-220439","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2021-220439","pdf_url":"https://ard.bmj.com/content/annrheumdis/80/11/1483.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:7441362","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC8522452","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:34158371","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34158371","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the rheumatic diseases","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8522452","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8522452/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ann Rheum Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2021-220439","doi":"https://doi.org/10.1136/annrheumdis-2021-220439","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2021-220439","pdf_url":"https://ard.bmj.com/content/annrheumdis/80/11/1483.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320326474","display_name":"Teijin Pharma","ror":"https://ror.org/001144c36"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3175225331.pdf","grobid_xml":"https://content.openalex.org/works/W3175225331.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1837457471","https://openalex.org/W1942763327","https://openalex.org/W2086197387","https://openalex.org/W2126854279","https://openalex.org/W2156131531","https://openalex.org/W2335302945","https://openalex.org/W2409527952","https://openalex.org/W2521380741","https://openalex.org/W2761615158","https://openalex.org/W2765452810","https://openalex.org/W2889116610","https://openalex.org/W2922206684","https://openalex.org/W3016659031","https://openalex.org/W3023256684","https://openalex.org/W3035902331","https://openalex.org/W3037804099","https://openalex.org/W3038080478","https://openalex.org/W3087525211","https://openalex.org/W3113884715","https://openalex.org/W4229537562"],"related_works":["https://openalex.org/W3035902331","https://openalex.org/W2523541014","https://openalex.org/W4317568246","https://openalex.org/W2910502067","https://openalex.org/W2949912831","https://openalex.org/W2755508791","https://openalex.org/W2022967311","https://openalex.org/W2888949772","https://openalex.org/W3087525211","https://openalex.org/W2049913374"],"abstract_inverted_index":{"OBJECTIVES:":[0],"In":[1,176],"patients":[2,154,164],"with":[3,50,70,160,205,215,236,244],"gout,":[4],"treating":[5],"to":[6,19,95,186,201],"target":[7],"serum":[8],"uric":[9],"acid":[10],"levels":[11],"(sUA)":[12],"of":[13,41,85,101,144,223],"\u22646.0":[14,158,232],"mg/dL":[15,73,159,169,233],"is":[16,25],"universally":[17],"recommended":[18],"prevent":[20],"gout":[21,46,86,102,118,145,149,188,224],"flare.":[22],"However,":[23],"there":[24],"no":[26],"consensus":[27],"on":[28,208],"asymptomatic":[29,51,151,206,237],"hyperuricaemia.":[30,52],"Using":[31],"Japanese":[32],"health":[33],"insurance":[34],"claims":[35],"data,":[36],"we":[37],"explored":[38],"potential":[39],"benefits":[40],"sUA":[42,71,121,157,166,230],"control":[43,122],"for":[44,80,91,110,147,184],"preventing":[45],"flare":[47,103,119,189,225],"in":[48,153,163,203,234,242],"subjects":[49,135,204,217,235],"METHODS:":[53],"This":[54],"retrospective":[55],"cohort":[56],"study":[57],"analysed":[58],"the":[59,192],"JMDC":[60],"Claims":[61],"Database":[62],"from":[63],"April":[64],"2012":[65],"through":[66],"June":[67],"2019.":[68],"Subjects":[69],"\u22658.0":[72,219],"were":[74,104,172,226],"identified,":[75],"and":[76,98,120,150],"disease":[77,107],"status":[78,108],"(prescriptions":[79],"urate-lowering":[81],"therapy":[82],"(ULT),":[83],"occurrence":[84],"flare,":[87,146],"sUA)":[88],"was":[89,123,132,194],"investigated":[90],"1":[92],"year.":[93],"Time":[94],"first":[96,187],"onset":[97],"incidence":[99],"rate":[100],"determined":[105],"by":[106,179,228],"subgroups":[109],"2":[111],"years":[112],"or":[113,170],"more.":[114],"The":[115,129],"relationship":[116],"between":[117],"assessed":[124],"using":[125],"multivariable":[126],"analysis.":[127],"RESULTS:":[128],"analysis":[130,178],"population":[131],"19":[133],"261":[134],"who":[136,155,171],"met":[137],"eligibility":[138],"criteria.":[139],"We":[140],"found":[141],"fewer":[142],"occurrences":[143],"both":[148],"hyperuricaemia,":[152],"achieved":[156],"ULT":[161,209],"than":[162],"whose":[165],"remained":[167],">6.0":[168],"not":[173],"receiving":[174],"ULT.":[175],"particular,":[177],"a":[180],"Cox":[181],"proportional-hazard":[182],"model":[183],"time":[185],"indicated":[190],"that":[191],"HR":[193],"lowest,":[195],"at":[196,231],"0.45":[197],"(95%":[198],"CI":[199],"0.27":[200],"0.76),":[202],"hyperuricaemia":[207,238],"(5.0